Market Entry Strategies in the US for an In-Vitro Diagnostic (IVD) Manufacturer in Women's Health

CHALLENGE

A top 10 pharmaceutical company tapped a boutique consulting firm to dive into market entry strategies for an In-Vitro Diagnostic (IVD) manufacturer focusing on women's health in the US. The goal was to uncover the most effective pathways for launching an IVD product, navigating regulatory hurdles, and capturing market share in this competitive field.

BTHT APPROACH

After a dynamic kickoff with the consulting firm and a deep dive into the project’s aims, the BTHT team sprang into action. They reached out to high-level experts, specifically CEOs of leading analytical and medical laboratories, who are well-versed in the intricacies of the IVD market. The team set up a series of engaging and insightful expert calls, ensuring each discussion was not only informative but also seamlessly executed.

OUTCOME

The BTHT team succeeded in connecting the client with influential CEOs from top analytical and medical labs, providing a goldmine of insights into the US market for IVDs in women's health. These conversations revealed practical strategies for market entry, from regulatory navigation to competitive positioning. The expert input offered the consulting firm a robust and actionable roadmap, empowering the pharmaceutical company to make strategic decisions and effectively launch their IVD product in the US market.